ReviewPharmaceuticals (Basel, Switzerland)2022
A Review of the Safety of Interleukin-17A Inhibitor Secukinumab.
Vishnu Eshwar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this paperpooled ittrialcites it
ReviewPharmaceuticals (Basel, Switzerland)2022
Vishnu Eshwar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.